Objectives: Data describing long-term outcomes following ICU for patients with alcohol-related liver disease are scarce. We aimed to report long-term mortality and emergency hospital resource use for patients with alcohol-related liver disease and compare this with two comparator cohorts. Design: Retrospective cohort study linking population registry data. Setting: All adult general Scottish ICUs (2005ICUs ( -2010 serving 5 million population. Patients: ICU patients with alcohol-related liver disease were compared with an unmatched cohort with Acute Physiology and Chronic Health Evaluation defined diagnoses of severe cardiovascular, respiratory, or renal comorbidity and a matched general ICU cohort.
A recent Lancet commission addressing liver disease advocated widened access to critical care (12) . However, a shared decision-making process between clinicians, patients, and families should precede admission balancing burdens and benefits (13) . These stakeholders need to understand the consequences of critical care admission based on robust evidence. Few studies have reported long-term outcomes for critically ill patients with ALD, and none describe both long-term mortality and hospital readmission rates for a complete national cohort (5) . This is particularly important given the increasing evidence of the burden associated with ICU survivorship (14) .
To inform these knowledge gaps, we analyzed a national cohort of patients admitted with ALD identified from the Scottish ICU registry in order to (1) report 5-year mortality, emergency readmission risk, and subsequent acute hospital resource used in comparison to two cohorts of ICU patients: one with severe chronic diseases known to be independently associated with poor outcomes and a second comprising matched general ICU patients; and (2) identify risk factors for early and late mortality and 5-year emergency readmission risk. We hypothesized that patients with ALD would have greater long-term morbidity and mortality compared with general ICU patients, but not patients with severe chronic diseases.
METHODS

Design, Setting, and Data Sources
We used a cohort study design using the following linked registries: the Scottish Intensive Care Society Audit Group (SICSAG), Scottish Morbidity Record of acute hospital admissions (SMR01), and Scottish death records. The SIC-SAG registry captures all adult general intensive care activity within Scotland (15) . Between 2005 and 2010, all 24 adult general ICUs, serving a population of 5.1 million (4.2 million ≥ 16 yr old), submitted data. Approvals were obtained from the relevant data-governing body (Privacy Advisory Committee, Information Services Division: reference 55/09). All data were anonymized prior to release to the researchers. The South East Scotland Research Ethics Committee granted a waiver (reference NR/1001AB14).
Population
The ALD cohort comprised Scottish residents greater than or equal to 16 years old with an ALD diagnosis admitted to general Scottish ICUs over a 6-year period (January 1, 2005 to December 31, 2010; index admission). We excluded elective ICU admissions and those undergoing liver transplantation. Only first ICU admissions with a valid linkage number were included where there were multiple admissions.
ALD diagnosis was defined by combining SICSAG and SMR01 data sources as following: 1) presence of a SICSAG ICU admission diagnosis code of ALD coded on the index ICU admission or 2) presence of an SMR01 diagnosis code of ALD (International Classification of Diseases, 10th Revision, codes K700-K709 inclusive) on the index hospital SMR01 record or in the 1-year preceding ICU admission. Coding in both SICSAG and SMR01 datasets has been validated and demonstrated to be accurate (16, 17) .
We used two comparator cohorts: We chose the first comparator cohort because the presence of severe chronic disease may influence clinician decisionmaking in relation to ICU admission and ongoing treatment decisions in a similar way that the presence of ALD may influence clinical management (20) . We chose the second comparator cohort to benchmark outcomes against a general ICU population.
Variables
Variables included demographics, preadmission factors, and factors relating to the ICU/hospital stay. SES was measured by the Social Index of Multiple Deprivation (SIMD) (21) . Comorbidity was measured using a combination of Charlson and SIC-SAG-defined comorbidity (see [22] for details of comorbidity derivation). ICU admission diagnosis was grouped by organ system for ALD versus comorbid cohort comparisons. Highest bilirubin in the first 24 hours of ICU admission was categorized using Sequential Organ Failure Assessment (SOFA) score thresholds to produce a liver SOFA score (23) . For full list of variables and confounders used in multivariable models to adjust outcomes for ALD versus comparator cohorts, see online supplement (Supplemental Digital Content 1, http:// links.lww.com/CCM/D993).
Outcomes and Follow-Up Period
The primary outcomes were 5-year mortality, emergency hospital resource use, and cumulative risk of first hospital readmission obtained from linkage to Scottish death records and SMR01 registries. For further information relating to outcomes and cause-specific readmission analyses, see online supplement (Supplemental Digital Content 1, http://links.lww. com/CCM/D993). Follow-up was censored on January 1, 2011, or after 5-year follow-up and commenced on ICU admission for mortality analyses and index hospital discharge for readmission/resource use analyses.
Statistical Analysis
Analyses were undertaken using Stata IC Version 13 (StataCorpLP, College Station, TX) and SAS (SAS Institute, Cary, NC). Baseline characteristics were compared between ALD and comorbid comparator cohorts using t test, Mann-Whitney U, or chi-square tests. A complete case analysis was undertaken. Missing liver SOFA score was included as an independent category. We used Kaplan-Meier estimates to report mortality to 5 years. Cox regression was used to identify independent predictors of mortality for early (0-30 d) and late (31 d to 5 yr) periods in the ALD cohort. z score and likelihood ratio tests were used to assess significance of individual and all categories of predictors respectively. Cumulative risk of first emergency hospital readmission was estimated using cumulative incidence function (Stata commands:"stcompet";"stccreg"). Fine-Gray regression was used to identify independent predictors of first emergency readmission risk in the ALD cohort allowing for the competing risk of death (24) . Comparisons between ALD and comparator cohorts were undertaken with adjustment for confounders using the multivariable regression models (details in online supplement, Supplemental Digital Content 1, http:// links.lww.com/CCM/D993).
Subgroup and Additional Analyses
We stratified results within the ALD cohort for patients with and without cirrhosis as outcomes were likely to differ between groups. We presented subgroup analyses for ALD patients and comparator populations for mortality outcomes for the four commonest ICU admission diagnoses: pneumonia, septic shock, acute abdominal pathology, and postcardiac arrest. The rationale for subgroup analyses was to reduce the heterogeneity present in comparisons undertaken at a whole population level in order to better investigate the effect of ALD on outcomes. See online supplement (Supplemental Digital Content 1, http://links.lww.com/CCM/ D993) for full definitions of cirrhosis and admission diagnoses. As the primary analysis with the severe comparator comorbid cohort was unmatched, we undertook a matched analysis to identify the presence of residual confounding in the unmatched analysis. Table 1) .
RESULTS
ALD
The most common ICU admission diagnoses in the ALD cohort were variceal hemorrhage (18%), pneumonia (17%), and septic shock (12%). More ALD patients than those with other severe comorbidities required mechanical ventilation on the day of admission (77.6% vs 67.1%; p < 0.001). The median ICU length of stay was longer in ALD patients (2.7 vs 2.2 d; p < 0.001), but median index hospital length of stay was shorter (12 vs 14 d; p < 0.001).
ALD Versus Matched General ICU Cohort
For the matched general ICU population, 2,391 of ALD patients (97.1%) could be matched to 2,391 general ICU patients without ALD (Fig. 1) . Sex, SES, and APS/APACHE score were similar between groups with minor imbalances in age, and admission source (eTable 1, Supplemental Digital Content 1, http://links.lww.com/CCM/D993). ALD patients required more organ support (p < 0.001) had a similar ICU length of stay, but shorter hospital stay. Unmatched ALD cohort members were more severely ill, requiring more organ support and with higher ICU mortality (eTable 2, Supplemental Digital Content 1, http://links.lww.com/CCM/D993).
Early and Late Mortality
In the ALD cohort, ICU mortality was 44.1% (95% CI, 42.2-46.1%) and a further 361 died in hospital after ICU discharge (hospital mortality, 58.8%; 95% CI, 56.8-60.7%). Using fixed time-point outcomes, 30-day mortality was 54.9% (95% CI, 53.0-56.9%) increasing to 66.1% and 79.2% at 1-and 5-years (Fig. 2) . Median survival was 17 days (interquartile range, 2-563 d).
Five-year mortality was greater in the ALD cohort than the comparator cohort with severe comorbidities (79.2% vs 75.3%) and the matched general ICU cohort (79.1% vs 62.1%) (Fig. 2) . After adjustment for confounders, there was a 31% relative excess in 5-year hazard of death in the ALD cohort compared with the severe comorbid cohort (adjusted hazard ratio [HR], 1.31; 95% CI, 1.16-1.47; p < 0.001) and 53% excess in comparison with the general ICU cohort (adjusted HR, 1.53; 95% CI, 1.35-1.74; p < 0.001) (Fig. 3) . Point estimates of excess hazard of death were similar in both early and late periods in both comparator cohorts (Fig. 3) .
Patients requiring three organ support (79.0%), admitted after a cardiac arrest (80.9%) (eFig. 1, Supplemental Digital Content 1, http://links.lww.com/CCM/D993) and with a liver SOFA score of 4 (77.6%) had the highest 30-day mortality rates. Age, admission source, diagnosis on ICU admission, number of organs supported, and admission liver SOFA score were independent predictors of early (0-30 d) and late (31 d to 5 yr) mortality ( Missing data: admission source n = 6, organ support variables n = 26, Acute Physiology Score n = 398, and Acute Physiology and Chronic Health Evaluation II score n = 38. For comparisons between alcohol-related liver disease (ALD) and comorbid comparator cohort, a count of comorbidities excluded the index comorbidity (e.g., ALD cohort members could not have "liver disease" as a comorbidity). (Fig. 3) .
The strongest predictor of first emergency readmission in the ALD cohort was the number of inpatient admissions in the year before ICU admission (χ 2 = 121; 4 degrees of freedom; p < 0.001) (eTable 4, Supplemental Digital Content 1, http://links.lww.com/CCM/ D993). Other independent predictors were number of organs supported, age, SES, diagnosis at admission, APS, and liver SOFA score.
Subgroup Analyses and Additional Analyses
Within the ALD cohort, twothirds of patients had a diagnosis of cirrhosis coded. These patients were younger, were less severely ill (measured by APS), and required less organ support at admission compared with ALD patients without cirrhosis (eTable 5, Supplemental Digital Content 1, http://links. lww.com/CCM/D993). However, cirrhosis patients experienced higher 5-year mortality, resource use, and costs (eTable 6, Supplemental Digital Content 1, http://links.lww.com/ CCM/D993). Adjusted analyses for mortality, cumulative incidence of first emergency readmission, and emergency readmission rate in alcohol-related liver disease (ALD) cohort compared with comparator cohorts with other severe comorbidities and matched general ICU patients. Point estimates are hazard ratios for all outcomes other than 5-year readmission rate which is the admission rate ratio. For each of the four commonest ICU admission diagnoses (pneumonia, septic shock, postcardiac arrest, and acute abdominal pathology), the ALD cohort had higher adjusted 5-year mortality compared with both severe comorbid, and general ICU cohorts (Fig. 3) . The matched analysis with the severe comorbid cohort confirmed the findings of the primary unmatched analysis (eTable 7, Supplemental Digital Content 1, http://links.lww.com/CCM/D993).
DISCUSSION
In a complete, national database of ICU admissions, patients with a diagnosis of ALD experienced higher long-term mortality and emergency readmission rates compared with ICU patients with other severe comorbidities and a matched general ICU cohort. For every three patients admitted to ICU with ALD, two had died within 1 year of ICU admission. In those surviving their index hospitalization, acute emergency readmission rates were highest in the first year of follow-up with almost half of readmissions related to liver disease or alcohol-related conditions. Morbidity and mortality were higher in those with cirrhosis. These findings highlight the substantial long-term burden experienced by patients with ALD after ICU admission.
The presence of ALD is often viewed as a poor prognostic marker in critically ill patients considered for admission to ICU (5, 20, 25) . Our results, reporting the largest cohort to date, confirm this to be the case, even when compared with a cohort with other severe comorbidities. No previous research has reported hospital readmission rates or healthcare resource use for ICU survivors with ALD. Elevated readmission rates in general ICU survivor cohorts may in part be attributable to morbidity associated with surviving ICU ("postintensive care syndrome" [PICS]) (14, 22, 26) . Superimposing a PICS on ALD patients already on a declining chronic disease trajectory may result in a particularly vulnerable patient group. However, in this study, almost half of early emergency readmissions in the ALD survivor cohort were caused by liver/alcohol-related conditions suggesting that the underlying disease, rather than other consequences of critical illness, were more important drivers of readmission.
Comparison of our data with studies of non-ICU hospital in patients with liver disease reveals conflicting results. Hospital 30-day readmission was higher than in patients with advanced liver disease of any etiology (27) (26.6% vs 20%) but lower than in patients with cirrhosis-related complications (26.6% vs 37%) (8) . The reasons for this may relate to differences in case-mix and/or healthcare organization. In the first cohort, only readmissions to the same institution were included which may have underestimated readmission rates (27) . Furthermore, members of our cohort had been selected by clinicians at the time of ICU admission resulting in likely lower prevalence of frailty, which can influence ICU admission decision-making (28) .
Strengths and Limitations
Our study has a number of strengths. We used linked databases with complete coverage in Scotland for ICU admissions ensuring robust, long-term follow-up for mortality, and readmission rates. Furthermore, we captured readmissions to any Scottish hospital, unlike other studies that were limited to single centers. Our findings were robust when benchmarked against two comparator cohorts, general ICU patients and those with severe comorbidities, as well as in more homogeneous subgroups defined by ICU admission diagnosis. However, the study was conducted in a single country, and the results may reflect region-specific societal, cultural, and clinical practices. Readers should, therefore, exercise caution when generalizing the findings to other countries. A limitation of our work was that we could only grade severity of ALD using the SOFA liver score. Liver-specific disease scores such as Child-Pugh score were not available. However, in a recent study of critically ill patients with cirrhotic liver disease, ICU-specific scores demonstrated similar ability to predict mortality compared with liver-specific scores (29) . Furthermore, a systematic review of scores showed Child-Pugh score is likely the weakest discriminator of mortality (4, 30) .
We used retrospectively collected registry data to define the study cohort by combining diagnostic coding in ICU and hospital datasets, which could have misclassified some patients. However, in Scottish datasets, case-note validation of ICU diagnosis coding has been shown to be of "very high quality" (17) and coding accuracy in hospital datasets approaches 90% for the primary diagnosis code (16).
Unlike severe cardiovascular and respiratory comorbid illnesses, patients with ALD who remain abstinent through treatment for alcohol dependency have reduced long-term mortality (31) . We were unable to identify such patients in our cohort.
Implications for Clinical Practice and Future Work
Our findings have implications for clinical practice and health policy. Our data can inform discussions between clinicians, patients, and families relating to the consequences of admission to critical care in the context of ALD. There is a risk that population level data exacerbate the stigma, which may be associated with ALD or may promote a self-fulfilling prophecy of high mortality if used to apply a blanket denial of critical care admission. Nuanced decision-making is needed, in conjunction with hepatologists, patients and families to fully consider an individual patient's circumstances and their perspective on balancing burdens of treatment with benefits. Our data provide a valuable resource in such discussions. High postdischarge healthcare resource use for ICU survivors with ALD may highlight improvements that are needed in community strategies to reduce alcohol-dependence and optimizing chronic disease management for the subgroup with alcoholrelated cirrhosis.
There have been recent calls for targeted discussions with patients with end-stage chronic liver disease to ensure their treatment wishes are fully understood after an admission to hospital (32) . These discussions may involve shared decisionmaking relating to treatment escalation, anticipatory care planning, and referral to palliative care services. National guidelines recommend this process for patients with severe respiratory and heart disease, who comprised a high proportion of our comparator cohort (33, 34) . Given outcomes were significantly worse among the ALD cohort than those with severe chronic comorbidities, our study highlights the need for clinicians to better recognize patients with end-stage liver disease, and consider similar anticipatory planning where appropriate.
CONCLUSIONS
In summary, patients admitted to ICU with ALD experience higher mortality and hospital readmission rates than patients with other severe chronic diseases and similar general ICU patients. Our data provide important information that can be used to inform shared decision-making for clinicians and patients with ALD.
